AAAAAA

   
Results: 1-11 |
Results: 11
A 48-year-old woman with diffuse pulmonary calcinosis after renal transplantation. A rarely observed complication of tertiary hyperparathyroidism
Authors: Leingartner, T Fischereder, M Luchner, A Riegger, GAJ Kramer, BK
Citation: T. Leingartner et al., A 48-year-old woman with diffuse pulmonary calcinosis after renal transplantation. A rarely observed complication of tertiary hyperparathyroidism, MED KLIN, 96(7), 2001, pp. 408
Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene
Authors: Fischereder, M Schneeberger, H Lohse, P Kramer, BK Schlondorff, D Land, W
Citation: M. Fischereder et al., Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene, AM J KIDNEY, 38(5), 2001, pp. 1061-1064
Severe hypertension and massive osteoporosis as presenting symptoms of Cushing's syndrome
Authors: Endemann, DH Fischereder, M Leingartner, T Stubanus, M Zietz, B Riegger, GAJ Kramer, BK
Citation: Dh. Endemann et al., Severe hypertension and massive osteoporosis as presenting symptoms of Cushing's syndrome, AM J NEPHR, 21(3), 2001, pp. 245-248
CC chemokine receptor 5 and renal-transplant survival
Authors: Fischereder, M Luckow, B Hocher, B Wuthrich, RP Rothenpieler, U Schneeberger, H Panzer, U Stahl, RAK Hauser, IA Budde, K Neumayer, HH Kramer, BK Land, W Schlondorff, D
Citation: M. Fischereder et al., CC chemokine receptor 5 and renal-transplant survival, LANCET, 357(9270), 2001, pp. 1758-1761
Inhibition of renin secretion by angiotensin II receptor blockage?
Authors: Kramer, BK Endemann, D Fischereder, M Wolf, K
Citation: Bk. Kramer et al., Inhibition of renin secretion by angiotensin II receptor blockage?, KIDNEY INT, 60(4), 2001, pp. 1612-1612
Renal transplantation in a patient with end stage renal disease due to cholesterol embolism
Authors: Kammerl, MC Fischereder, M Zulke, C Obermann, EC Anthuber, M Riegger, GAJ Kramer, BK
Citation: Mc. Kammerl et al., Renal transplantation in a patient with end stage renal disease due to cholesterol embolism, TRANSPLANT, 71(1), 2001, pp. 149-151
Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2
Authors: Kanmerl, MC Nusing, RM Schweda, F Endemann, D Stubanus, M Kees, F Lackner, KJ Fischereder, M Kramer, BK
Citation: Mc. Kanmerl et al., Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2, CLIN PHARM, 70(5), 2001, pp. 468-474
The HOPE study and diabetes
Authors: Stubanus, M Endemann, D Fischereder, M Ittner, KP Kramer, BK
Citation: M. Stubanus et al., The HOPE study and diabetes, LANCET, 355(9210), 2000, pp. 1183-1183
Renal side-effects of cyclo-oxygenase-type-2 inhibitor use
Authors: Stubanus, M Riegger, GAJ Kammerl, MC Fischereder, M Kramer, BK
Citation: M. Stubanus et al., Renal side-effects of cyclo-oxygenase-type-2 inhibitor use, LANCET, 355(9205), 2000, pp. 753-753
Early graft failure with thrombophilia and effects of anticoagulation
Authors: Fischereder, M Schneeberger, H Gohring, P Hillebrand, G Schlondorff, D Land, W
Citation: M. Fischereder et al., Early graft failure with thrombophilia and effects of anticoagulation, TRANSPLAN P, 31(1-2), 1999, pp. 360-361
Biocompatibility of renal replacement therapy
Authors: Schiffl, H Fischereder, M Sitter, T
Citation: H. Schiffl et al., Biocompatibility of renal replacement therapy, INTERNIST, 40(1), 1999, pp. 37-48
Risultati: 1-11 |